NA CC101020Recalls & reported problems
Boston Scientific Neuromodulation Corporation · Cannula, 10cm,10mm tip,20G Sharp Straight · Class 2
Data updated Oct 13, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00813250012712), received between Mar 12, 2018 and May 9, 2018 — classified as 2 injuries.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
Patient problems
- Hypersensitivity/Allergic reaction2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryMay 9, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A REPORT WAS RECEIVED THAT TWO WEEKS AFTER A RADIOFREQUENCY PROCEDURE THE PATIENT EXPERIENCED A REACTION THAT WERE INITIALLY ASSESSED TO BE BURN MARKS AT THE PUNCTURE SITE. THE SIZES OF THE MARKS WERE LESS THAN 1 CENTIMETER AND WERE LOCATED AT L3-S1. DURING THE PROCEDURE IT WAS NOTED THAT THE PHYSICIAN INJECTED 1-2 ML OF TRIGON 400 MG/ML WITH SALINE THROUGH THE CANNULAS. THEY DID NOT USE ANY SKIN PREPARATION OR DRESSING THAT COULD HAVE GOTTEN INTO THE PUNCTURE SITE. THE PHYSICIAN FELT THAT MARKS WERE RELATED TO USE OF THE CANNULA, AND LATER ASSESSED THAT HE DOESN¿T KNOW THE CAUSE OF THE REACTION BUT BELIEVE IT COULD BE AN ALLERGIC REACTION. THE PATIENT WAS ADMINISTERED A TWO MONTH PRESCRIPTION FOR CORTICOID OINTMENT THE PATIENT IS DOING FINE. THERE IS NO FURTHER COURSE OF ACTION.
Patient problems: Hypersensitivity/Allergic reaction
MAUDE report 7499015 ↗InjuryMar 12, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A REPORT WAS RECEIVED THAT AFTER A RADIOFREQUENCY PROCEDURE THE PATIENT EXPERIENCED A REACTION THAT WERE INITIALLY ASSESSED TO BE BURN MARKS AT THE PUNCTURE SITE. DURING THE PROCEDURE IT WAS NOTED THAT THE PHYSICIAN INJECTED 1-2 ML OF TRIGON 400 MG/ML WITH SALINE THROUGH THE CANNULAS. THEY DID NOT USE ANY SKIN PREPARATION OR DRESSING THAT COULD HAVE GOTTEN INTO THE PUNCTURE SITE. THE PHYSICIAN FELT THAT MARKS WERE RELATED TO USE OF THE CANNULA, AND LATER ASSESSED THAT HE DOESN'T KNOW THE CAUSE OF THE REACTION BUT BELIEVE IT COULD BE AN ALLERGIC REACTION. THE PATIENT WAS ADMINISTERED A PRESCRIPTION FOR CORTICOID AND THE PATIENT IS DOING FINE. THERE IS NO FURTHER COURSE OF ACTION.
Patient problems: Hypersensitivity/Allergic reaction
MAUDE report 7332979 ↗
Other PROBE, RADIOFREQUENCY LESION devices
- NA TCN-15Boston Scientific Neuromodulation Corporation · PROBE, RADIOFREQUENCY LESION2 recalls10 reports
- NA TCN-10-3MBoston Scientific Neuromodulation Corporation · PROBE, RADIOFREQUENCY LESION2 recalls9 reports
- NA CSK-TC10Boston Scientific Neuromodulation Corporation · PROBE, RADIOFREQUENCY LESION1 recall1 death58 reports
- NA CLASSICSt. Jude Medical, Inc. · PROBE, RADIOFREQUENCY LESION1 recall40 reports
- Intracept RLV 0055Relievant Medsystems, Inc. · Probe, Radiofrequency Lesion1 recall30 reports
- Intracept RLV 0045Relievant Medsystems, Inc. · Probe, Radiofrequency Lesion1 recall1 death23 reports
- Intracept RLV0065Relievant Medsystems, Inc. · Probe, Radiofrequency Lesion1 recall14 reports
- Intracept RLV 0075Relievant Medsystems, Inc. · Probe, Radiofrequency Lesion1 recall3 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 13, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 13, 2026
- Page last rebuilt: Oct 13, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page